ReviewTherapeutics and clinical risk management2014

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.

Grigoris T Gerotziafas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.